Stay updated on Clinical Trial: Inotuzumab Dose Study in ALL
Sign up to get notified when there's something new on the Clinical Trial: Inotuzumab Dose Study in ALL page.

Latest updates to the Clinical Trial: Inotuzumab Dose Study in ALL page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer revision indicator changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check11 days agoChange DetectedA notice was added about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” across its content.SummaryDifference0.3%

- Check18 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check25 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check46 days agoChange DetectedA new revision entry labeled v3.7.0 was added to the study record history. The previous revision label v3.6.6 was removed, indicating an update to the record's revision history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe record history now shows an added Revision: v3.6.6 and a removed Revision: v3.6.5, indicating an upgrade of the history page's underlying platform. This is an internal version update rather than changes to study data or page content.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Inotuzumab Dose Study in ALL
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Inotuzumab Dose Study in ALL page.